Oxytocin appears twice in the catalogue. Oxytocin is listed as a lyophilised vial at $14.00, and Oxytocin Liquid Spray at 10 mg in 10 mL at $65.12. The gap between those two numbers is not a pricing error, and understanding what separates them is most of what a buyer needs to decide between them.
This covers the molecule as a chemical object, what its structure means for stability and for identity testing, how the two formats differ as purchases, and what to read on the certificate. Everything about biological activity below is reported from published work and named by model. The material is supplied for laboratory research only.
| Compound | Vial strengths | Molecular weight | Amino acids |
|---|---|---|---|
| Oxytocin | 2 mg, 10 mg | 1007.19 g/mol | 9 |
| Oxytocin Liquid Spray | 10 mg · 10 mL | 1007.19 g/mol | 9 |
From the Restate Health catalog records. Lot-specific values are on each certificate of analysis.
A nine-residue cyclic peptide
Oxytocin is a nonapeptide — nine amino acid residues — with a molecular weight near 1007 daltons. Its defining structural feature is a disulfide bridge between the cysteine residues at positions 1 and 6, which closes six of the nine residues into a ring and leaves a short three-residue tail. It is one of the earliest peptides to have been synthesised chemically, and it remains a standard reference structure in peptide chemistry teaching for exactly that reason.
The ring is the interesting part for anyone buying it. A disulfide bridge is a covalent bond between two sulfur atoms, and it is the most chemically fragile feature a short peptide can carry. It is vulnerable to reduction, to oxidation past the disulfide to higher sulfur oxidation states, and to disulfide scrambling, where the bond re-forms between the wrong partners in a mixture.
Gonadorelin, kisspeptin, oxytocin and HCG sets the molecule alongside the other reproductive-axis compounds it is usually catalogued with, which are chemically very different from each other despite the shared shelf.
What the bridge means for the certificate
Two consequences, and both change how a certificate should be read.
The first is that mass spectrometry alone is a weaker identity test here than it is for a linear peptide. A scrambled disulfide, a reduced form that has re-oxidised incorrectly, and the correct molecule can share a mass or differ by an amount easy to overlook. Identity for a cyclic peptide is properly established by chromatographic behaviour alongside mass, not by mass alone. Mass spectrometry and peptide identity covers what the technique does and does not prove.
The second is that related-substance content matters more than usual. The impurities of concern are not only deletion sequences from synthesis but oxidation and scrambling products that form after synthesis, during storage and handling. Peptide impurities explained covers the categories, and how peptides degrade covers the chemistry that generates them.
A certificate worth having states purity by a named chromatographic method with the gradient conditions, reports related substances rather than only a single purity figure, and gives net peptide content. Reading a certificate of analysis line by line covers the full read.
Vial against liquid spray
The two listings are not the same purchase in different packaging. They differ in what is being sold, in how long it lasts and in what you are trusting.
| Lyophilised vial | Liquid spray | |
|---|---|---|
| Catalogue price | $14.00 | $65.12 |
| Stated content | Vial of lyophilised solid | 10 mg in 10 mL |
| State on arrival | Dry powder | Already in solution |
| Stability clock | Starts at reconstitution | Started at manufacture |
| Concentration | Set by the buyer | Set by the supplier |
| Key certificate line | Net peptide content | Content uniformity and fill volume |
The two oxytocin listings compared as purchases
The dry vial is the longer-lived product and the more flexible one. Lyophilised material is far more stable than material in solution, the buyer chooses the concentration, and the stability clock does not start until reconstitution. Lyophilisation explained covers why the powder form exists, and peptide shelf life covers the difference the two states make.
The spray is a prepared solution, and what you are paying the difference for is the preparation: a stated concentration, a filled and sealed container, and a uniformity specification across the fill. That is real work and it carries a real cost, but it also means the degradation clock has been running since manufacture rather than since you opened it. Nasal sprays and liquid formats covers what changes when a product is not a powder.
For a disulfide-bridged peptide this difference is sharper than for a robust linear sequence. Time in solution is the condition under which scrambling and oxidation occur, so a prepared liquid of a cyclic peptide is a product whose certificate should be recent and whose storage history should be known.
Storing a prepared liquid
A liquid product arrives with its degradation clock already running, which changes what storage is for. With a dry vial, storage preserves a stable material; with a solution, storage slows a process that is already under way.
Three things matter more for the spray than for the vial. Temperature, because reaction rates fall with it and a prepared solution has no other defence. Light, because photochemical routes are available to a molecule in solution that are largely closed to one in a dry cake — light sensitivity and amber glass covers which containers earn the darker glass. And time since manufacture rather than time since receipt, which is the number the label is least likely to show prominently.
Ask for the manufacture date at purchase if it is not printed. A re-test date alone tells you when the supplier stops standing behind the material, not how long it has already been in solution, and for a disulfide-bridged peptide those are materially different questions.
What the published work describes
Oxytocin is among the most extensively studied peptides in the literature, and the volume of that work is itself a buying consideration: methods for characterising it are well established, reference standards exist, and a supplier has no excuse for thin documentation on a molecule this well mapped.
The research spans receptor pharmacology, structural studies of the cyclic conformation, and a large body of work in animal models across several fields. All of it is laboratory and preclinical work, and none of it is reproduced here as a claim about any effect in people. What it means commercially is that a certificate for oxytocin should be judged against a mature analytical literature rather than against what is convenient for the supplier to measure.
Where a supplier's certificate for a well-characterised molecule is thinner than certificates for obscure ones elsewhere in the same catalogue, that is a signal about the supplier rather than about the compound. Comparing suppliers on documentation covers reading the pattern across a catalogue rather than a single page.
What to check before ordering
For the vial: net peptide content, purity by a named method, related substances, and the salt form. Net peptide content explains why the labelled mass and the peptide mass are different numbers, and at a $14.00 price point the difference between an 80 per cent and a 95 per cent net content is a larger proportion of the value than it first appears.
For the spray: the fill volume as well as the mass, the concentration those two imply, a content uniformity statement, and the date of manufacture rather than only a re-test date. A liquid product with a long-expired manufacture date and a comfortable re-test date is telling you less than it appears to.
For both: whether the certificate is published and verifiable rather than supplied on request. How to verify a certificate of analysis covers checking a document against the laboratory that issued it.
Handling
Store the dry vial cold and dark, and keep it dry — residual moisture is what drives hydrolysis in a lyophilised cake, and a disulfide-containing sequence has more to lose from it than most. Residual moisture in lyophilised peptides covers the test most certificates leave out.
Once reconstituted, minimise time in solution and minimise freeze-thaw cycling. Each cycle is an opportunity for aggregation and for the bridge to find the wrong partner. Freeze-thaw cycles and aliquoting covers aliquoting as the standard answer to that problem.
Avoid reducing conditions in anything the material contacts, and keep both formats out of direct light. Light sensitivity and amber glass covers which compounds warrant the darker container.

